WC Walker & Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.47M Sell
13,233
-68
-0.5% -$11.8K 1.31% 26
2022
Q3
$2.29M Sell
13,301
-1
-0% -$198 1.3% 26
2022
Q2
$2.69M Sell
13,302
-82
-0.6% -$17.4K 1.58% 21
2022
Q1
$3.2M Buy
13,384
+207
+2% +$48.6K 1.66% 19
2021
Q4
$2.94M Buy
13,177
+288
+2% +$63.4K 1.45% 24
2021
Q3
$2.49M Buy
12,889
+334
+3% +$67.7K 1.33% 29
2021
Q2
$2.68M Buy
12,555
+443
+4% +$93.5K 1.41% 26
2021
Q1
$2.48M Buy
12,112
+164
+1% +$32.3K 1.41% 24
2020
Q4
$2.33M Buy
+11,948
New +$2.03M 1.34% 27

Other funds holding CME

WC Walker & Associates's CME Position: Q4 2022 in Review

WC Walker & Associates reduced its CME Group (CME) stake by 0.51% in Q4 2022, selling an estimated $11.8K and leaving 13,233 shares worth $2.47M. The position accounts for 1.31% of the portfolio, ranked #26.

WC Walker & Associates first reported a position in CME in Q4 2020 and has held it in 9 quarters since. The position peaked at $3.2M in Q1 2022. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • WC Walker & Associates held 13,233 shares of CME Group worth $2.47M as of Q4 2022.
  • WC Walker & Associates sold 68 CME Group shares in Q4 2022, an estimated $11.8K.
  • CME Group made up 1.31% of WC Walker & Associates's portfolio in Q4 2022, its #26 holding.
  • WC Walker & Associates first reported a position in CME Group in Q4 2020 and has held it in 9 quarters since.
  • WC Walker & Associates's CME Group position peaked at $3.2M in Q1 2022.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on WC Walker & Associates's 13F filing for Q4 2022, filed 23 Feb 2023.